Colorado Actually Regulates Drug Costs, Digital Health Raises Billions Nobody Understands, and NeueHealth Gets Rescued by Its Own Investor

Hey all,

Happy Tuesday!  Colorado’s action on drug pricing is a harbinger of more state legislation. While it’s going to get tied up in court, it is encouraging to see states like Colorado and Arkansas pass aggressive reform measures. If only the federal government could pass a budget…

Enjoy the rundown!

Jacob Brody (Co-Founder & CEO, ZorroRX)

(STAT News) Colorado Board Sets Payment Cap on Amgen’s Enbrel Drug

In a groundbreaking decision, Colorado’s Prescription Drug Affordability Board voted to establish a $600 per-unit payment limit on Amgen’s arthritis medication Enbrel — the first such cap in the nation aimed at controlling high prescription drug costs. This move could serve as a model for other states seeking to rein in spending, potentially saving Coloradans $32 million annually, though Amgen and industry groups argue it constitutes unlawful price control that threatens patient access and innovation. Of course, they could’ve just all signed up for ZorroRX instead — that might’ve saved Coloradans over $50 million without the legal drama. Full Article

(Rock Health) Q3 2025 Digital Health Market Overview: Signals Out of Sync

 U.S. digital health funding reached $3.5B across 107 deals in Q3 2025, bringing the year-to-date total to $9.9B, ahead of 2024’s pace, though the market’s surface stability masks deeper turbulence. Persistent trends like unlabeled fundraising rounds (35% of deals) and a thinning Series B pipeline are distorting traditional growth benchmarks, while mega deals—such as Strive Health’s $550M raise—are concentrating capital among fewer players. Amid these shifts, workflow and infrastructure startups dominate funding, capturing 42% of sector investment and signaling healthcare’s operational backbone as the new innovation frontier. Incumbents like Epic, Oracle, and Innovaccer are embedding AI deeper into core systems, raising the bar for startups to prove ROI and differentiation. Full Article

(Fierce Healthcare) NeueHealth to Go Private in $1.3B Acquisition by New Enterprise Associates

Venture capital firm New Enterprise Associates (NEA) will acquire value-based care company NeueHealth—formerly Bright Health—for $1.3 billion, taking it private later this month. While the deal appears sizable, analysts note the true cash payout to public shareholders is only about $21 million due to NeueHealth’s $1.4 billion debt load, highlighting the steep decline from its nearly $80 share price in early 2023. The acquisition follows years of losses, debt, and divestitures as NeueHealth seeks stability under NEA’s control—and given how much NEA has already sunk into the startup, it’s only fitting they finally get to exit to themselves. Full Article